Published in Proc Natl Acad Sci U S A on October 01, 1982
Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci U S A (1985) 3.46
Expression of interleukin 2 receptors on activated human B cells. J Exp Med (1984) 3.27
Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J Exp Med (1984) 2.74
Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays. J Exp Med (1983) 2.56
Dendritic cells induce T lymphocytes to release B cell-stimulating factors by an interleukin 2-dependent mechanism. J Exp Med (1983) 2.42
Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function. J Exp Med (1985) 2.14
Production of a monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor/B-cell growth factor II. Proc Natl Acad Sci U S A (1987) 1.79
T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells. Proc Natl Acad Sci U S A (1987) 1.40
Soluble antigen abrogates the appearance of anti-protein IgG1-forming cell precursors during primary immunization. Proc Natl Acad Sci U S A (1990) 1.20
A high-efficiency cloning system for single hapten-specific B lymphocytes that is suitable for assay of putative growth and differentiation factors. Proc Natl Acad Sci U S A (1985) 1.11
Interleukin 1 can act as a B-cell growth and differentiation factor. Proc Natl Acad Sci U S A (1985) 1.08
Affinity-purified interleukin 2 induces proliferation of large but not small B cells. Proc Natl Acad Sci U S A (1985) 1.06
Human interleukin 2 can promote the growth and differentiation of single hapten-specific B cells in the presence of specific antigen. Proc Natl Acad Sci U S A (1984) 1.00
Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5. Proc Natl Acad Sci U S A (1988) 0.99
Synergistic effects of antigen and soluble T-cell factors in B-lymphocyte activation. Proc Natl Acad Sci U S A (1984) 0.96
Single cell studies on the role of B-cell stimulatory factor 1 in B-cell activation. Proc Natl Acad Sci U S A (1987) 0.91
Single-cell studies on hapten-specific B cells: response to T-cell-dependent antigens. Proc Natl Acad Sci U S A (1984) 0.75
T cells or their products are required for the differentiation of precursor B cells into antibody-secreting cells specific for a supposed T-independent self-antigen. Immunology (1987) 0.75
Identification of a T cell-derived b cell growth factor distinct from interleukin 2. J Exp Med (1982) 9.49
Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J Exp Med (1972) 6.47
Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J Exp Med (1979) 5.22
The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses. Immunol Rev (1982) 4.43
Two distinct factors are required for induction of T-cell growth. Nature (1980) 4.13
A third signal in B cell activation given by TRF. Transplant Rev (1975) 2.18
Induction of B cell differentiation by T cell factors. I. Stimulation of IgM secretion by products of a T cell hybridoma and a T cell line. J Immunol (1981) 1.73
Single cell studies on the antibody-forming potential of fractionated, hapten-specific B lymphocytes. Immunology (1976) 1.71
Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors. J Exp Med (1977) 1.67
Enhancement of the humoral response of T cell-depleted murine spleens by a factor derived from human monocytes in vitro. J Immunol (1974) 1.49
T cell replacing factors in the B cell response to antigen. Immunol Rev (1982) 1.44
Activation of murine B lymphocytes. III. Stimulation of B lymphocyte clonal growth with lipopolysaccharide and dextran sulfate. J Immunol (1981) 1.39
Sequential use of hapten-gelatin fractionation and fluorescence-activated cell sorting in the enrichment of hapten-specific B llymphocytes. Eur J Immunol (1978) 1.32
Macrophages and T cells control distinct phases of B cell differentiation in the humoral immune response in vitro. J Immunol (1980) 1.25
A con A-stimulated T-cell hybridoma releases factors affecting haematopoietic colony-forming cells and B-cell antibody responses. Nature (1980) 1.21
Nonspecific factors in B cell responses. Immunol Rev (1982) 1.14
The nature of the cells generating B-lymphocyte colonies in vitro. J Cell Physiol (1976) 1.14
Antibody production by single, hapten-specific B lymphocytes: an antigen-driven cloning system free of filler or accessory cells. Proc Natl Acad Sci U S A (1981) 1.10
Mechanisms of clonal abortion tolerogenesis. II. Clonal behaviour of immature B cells following exposure to anti-mu chain antibody. Immunology (1979) 1.01
Improved procedure for the fraction and in vitro stimulation of hapten-specific B lymphocytes. J Immunol (1978) 0.96
Activation of murine B cells. II. Dextran sulfate removes the requirement for cellular interaction during lipopolysaccharide-induced mitogenesis. Cell Immunol (1981) 0.95
T cell hybridoma-derived regulatory factors. I. Production of T cell growth factor following stimulation by concanavalin A. J Immunol (1981) 0.93
A simple semi-automated plaque method for the detection of antibody-forming cell clones in microcultures. J Immunol Methods (1982) 0.91
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (1996) 11.21
Synthesis of proteins by native chemical ligation. Science (1994) 10.98
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (1996) 9.25
Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell (2000) 8.69
Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukaemia. Lancet (1971) 7.25
Antigens in immunity. XV. Ultrastructural features of antigen capture in primary and secondary lymphoid follicles. J Exp Med (1968) 6.56
Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med (1996) 6.36
Human bone marrow colony growth in agar-gel. J Cell Physiol (1970) 5.82
Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet (1997) 5.58
Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice. J Exp Med (1968) 5.02
Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A (1991) 4.72
Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell (1997) 4.44
Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol (2000) 4.27
Cellular mechanisms of immunologic tolerance. Annu Rev Immunol (1983) 4.07
Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J (1997) 4.04
Antigens in immunity. 8. Localization of 125-I-labelled antigens in the secondary response. Immunology (1965) 4.00
Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science (2000) 3.75
Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest (1996) 3.74
Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J Exp Med (2001) 3.71
B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med (1998) 3.60
Inducible expression of H-2 and Ia antigens on brain cells. Nature (1984) 3.48
Quantitative features of a sandwich radioimmunolabeling technique for lymphocyte surface receptors. J Exp Med (1972) 3.28
Differentiation of lymphocytes in mouse bone marrow. II. Kinetics of maturation and renewal of antiglobulin-binding cells studied by double labeling. Cell Immunol (1974) 3.27
Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci U S A (1996) 3.16
The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response. EMBO J (1997) 3.09
Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem (2001) 3.03
Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry (1997) 2.87
Antigens in immunity. VII. Analysis of immunological memory. Immunology (1965) 2.65
Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature (1995) 2.65
Antigens in immunity. XII. Antigen trapping in the spleen. Int Arch Allergy Appl Immunol (1966) 2.62
Correlation of grain counts with radioactivity (125I and tritium) in autoradiography. Exp Cell Res (1966) 2.62
Evidence for the clonal abortion theory of B-lymphocyte tolerance. J Exp Med (1975) 2.61
RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. Cell Death Differ (2009) 2.59
A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science (1997) 2.58
Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett (1992) 2.57
Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J Immunol (1997) 2.51
HIV blocked by chemokine antagonist. Nature (1996) 2.50
Ligation-anchored PCR: a simple amplification technique with single-sided specificity. Proc Natl Acad Sci U S A (1992) 2.50
Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci U S A (1993) 2.45
Tolerance, enhancement and the regulation of interactions between T cells, B cells and macrophages. Transplant Rev (1972) 2.44
The phenotype and fate of the antibody-forming cells of the splenic foci. Eur J Immunol (1996) 2.42
Growth of B-lymphocyte colonies in vitro. J Exp Med (1975) 2.41
Functional interactions of viral and histocompatibility antigens at tumor cell surfaces. Proc Natl Acad Sci U S A (1975) 2.39
Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ (2008) 2.36
Antigen-driven B cell differentiation in vivo. J Exp Med (1993) 2.35
Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen. Genomics (1993) 2.33
Functional and molecular characterization of single, (4-hydroxy-3-nitrophenyl)acetyl (NP)-specific, IgG1+ B cells from antibody-secreting and memory B cell pathways in the C57BL/6 immune response to NP. Eur J Immunol (1992) 2.32
Neutrophil activation by monomeric interleukin-8. Science (1994) 2.31
Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J Immunol (1983) 2.30
Antigens in immunity. XIV. Electron microscopic radioautographic studies of antigen capture in the lymph node medulla. J Exp Med (1968) 2.29
Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. FASEB J (1994) 2.27
Growth of B lymphocyte colonies in vitro from mouse lymphoid organs. Nature (1975) 2.24
Neutrophil-activating properties of the melanoma growth-stimulatory activity. J Exp Med (1990) 2.17
Molecular characterization of single memory B cells. Nature (1991) 2.16
The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur J Immunol (1998) 2.15
The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur J Immunol (1997) 2.14
An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med (1997) 2.10
Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J Exp Med (1996) 2.08
Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues. J Exp Med (1995) 2.07
Participation of the H-2 antigens of tumor cells in their lysis by syngeneic T cells. J Exp Med (1976) 2.05
Clonal anergy: persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen. Proc Natl Acad Sci U S A (1980) 2.04
Caspase inhibitors. Cell Death Differ (1999) 2.02
Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci U S A (1997) 2.02
Interleukin-8 induces neutrophil transendothelial migration. Immunology (1991) 2.01
Mechanism of induction of immunological tolerance. IV. The effects of ultra-low doses of flagellin. Immunology (1968) 2.00
Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J Immunol (1996) 1.99
Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO J (1994) 1.97
The persisting (P) cell: histamine content, regulation by a T cell-derived factor, origin from a bone marrow precursor, and relationship to mast cells. Proc Natl Acad Sci U S A (1981) 1.97
Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides. Biochem J (1994) 1.94
The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes. J Biol Chem (1993) 1.92
Cell-mediated immune response in vitro. 3. The requirement for macrophages in cytotoxic reactions against cell-bound and subcellular alloantigens. J Exp Med (1972) 1.89
Electrophoretic analysis of antibody produced by single cells. Proc Natl Acad Sci U S A (1968) 1.89
Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol (1990) 1.86
The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem (2000) 1.86
Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ (2002) 1.85
Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev (1993) 1.84
Automated chemical synthesis of a protein growth factor for hemopoietic cells, interleukin-3. Science (1986) 1.84
The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies. J Immunol (1981) 1.83
Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. J Biol Chem (1991) 1.83
Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol (1991) 1.82
Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest (1998) 1.81
Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol (2001) 1.78
Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division. Proc Natl Acad Sci U S A (1999) 1.77
Effector cell blockade. A new mechanism of immune hyporeactivity induced by multivalent antigens. J Exp Med (1974) 1.75
T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity. Transplant Rev (1973) 1.74
Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat. Nat Struct Biol (1999) 1.73
Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin. Eur J Immunol (1984) 1.73
The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology (1997) 1.72
Single cell studies on the antibody-forming potential of fractionated, hapten-specific B lymphocytes. Immunology (1976) 1.71
Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J Exp Med (2000) 1.67